Exploiting the critical perioperative period to improve long-term cancer outcomes

Maya Horowitz,Elad Neeman,Eran Sharon,Shamgar Ben-Eliyahu

DOI: https://doi.org/10.1038/nrclinonc.2014.224

IF: 78.8

2015-01-20

Nature Reviews Clinical Oncology

Abstract:Key PointsThe perioperative timeframe—days before and after tumour excision—is pivotal in determining long-term cancer outcomes, disproportionally to its short durationPotential metastasis-promoting aspects of the perioperative period and of surgery include anxiety and stress, specific anaesthetics and analgesics, hypothermia, blood transfusion, tissue damage, specific sex hormones, nociception and painDeleterious processes include excess and maladaptive perioperative responses at the paracrine, endocrine, and immune-system levelsPotential novel interventions include specified modifications to surgical procedures, stress-reducing and anti-inflammatory approaches, such as perioperative administration of non-selective β-adrenergic blockers and COX2 inhibitors, and perioperative immune stimulationThese interventions could transform the perioperative timeframe from being a prominent facilitator of metastatic progression, to a yet unexplored opportunity for arresting and/or eliminating residual disease

oncology